Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2024 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Research Article
Pharmacological evaluation of anxiolytic activity of ethanolic extract of Hemidesmus indicus in rodent model
Saumya Malaiya *, Shailja Yadav, Harshita Jain, Arpit Shrivastava
Adina Institute of Pharmaceutical Sciences, Sagar (M.P), India
|
Article Info: ___________________________________________ Article History: Received 09 April 2024 Reviewed 02 June 2024 Accepted 26 June 2024 Published 15 July 2024 ___________________________________________ Cite this article as: Malaiya S, Yadav S, Jain H, Shrivastava A, Pharmacological evaluation of anxiolytic activity of ethanolic extract of Hemidesmus indicus in rodent model, Journal of Drug Delivery and Therapeutics. 2024; 14(7):43-50 DOI: http://dx.doi.org/10.22270/jddt.v14i7.6677 ___________________________________________ *Address for Correspondence: Saumya Malaiya, Adina Institute of Pharmaceutical Sciences, Sagar (M.P), India |
Abstract ___________________________________________________________________________________________________________________ The current study uses rodent models to explore the anxiolytic properties of Hemidesmus indicus' ethanolic extract (EEHI). Hemidesmus indicus, an evergreen plant well-known for its therapeutic characteristics, has been widely used in Ayurvedic medicine to treat a variety of conditions, including anxiety. This study seeks to give scientific validation for its anxiolytic properties. The ethanolic extract was made using normal extraction processes and given to rodents in varied doses (100,200 and 400 mg/kg). The anxiolytic activity was assessed using a variety of widely recognized behavioural assays, including the Elevated Plus Maze (EPM), Open Field Test (OFT), and Light-Dark Box (LDB) test. Diazepam (2 mg/kg) served as the standard reference drug. The results revealed that EEHI significantly reduced anxiety-like behaviours in all three tests when compared to the control group. In the EPM test, EEHI-treated rodents spent more time and entered the open arms. In the OFT, ambulation, rearing and assisted rearing increased, indicating lower levels of anxiety. The LDB test supported these findings, with a significant increase in time spent in the light compartment. The study suggests that EEHI has promising anxiolytic activity and may offer a natural treatment alternative for anxiety disorders. Further research is needed to isolate specific active molecules and better understand the underlying mechanisms of action.Keywords: Hemidesmus indicus, Anxiolytic activity, Rodent model, Elevated plus maze, Open field test, Light-dark box test. |
INTRODUCTION
The main class of drugs that are frequently administered to alleviate anxiety are benzodiazepines. However, using them is linked to negative effects including addiction risk, potentiation of other central depressant medications, and psychomotor impairment. Numerous plants are being researched for use as supplementary and alternative anxiety medications1,2. Studies have been carried out to find a different, more targeted, and affordable treatment. Hemidesmus indicus also known as Indian sarsaparilla in English, Anantmul in Hindi, and Ananta in Sanskrit language. It is a member of the Apocynaceae family that can be found throughout India, particularly in various territories of West Bengal. It is a thin, laticiferous, semi-erect and fragile bush, specifically known for its therapeutic properties3. It is reported that Indian traditional healers utilize it for nephritic symptoms, syphilis, and paediatric sore mouths. The decoction of roots is beneficial for skin conditions, syphilis, elephantiasis, anorexia, blood purification, and renal and urinary illnesses. It is commonly used in folk medicine and Ayurvedic and Unani preparations for treating biliousness, blood disorders, diarrhoea, skin illnesses, respiratory conditions, fever, asthma, eye diseases, burning sensation, arthritic conditions and gastric problems 4-6. Despite many reports in scientific publications on the uses of HI, relatively little research has been done on CNS applications. Because of this, the present study was taken to evaluate the anti-anxiety activity of the ethanolic extract from the roots of Hemidesmus indicus.
MATERIAL AND METHOD
Table 1: Anxiolytic activity profile on Number of entries (Mean ± SEM) in EPM apparatus of Hemidesmus indicus ethanolic extract.
|
GROUP NO. |
TREATMENT GROUP |
DOSE (mg/kg) |
Number of entries (Mean ± SEM) |
% OAE (percentage open arm entries) |
|
|
Open arm |
Closed arm |
||||
|
1 |
CONTROL |
saline |
7.33 ± 0.21 |
11.1 ± 0.47 |
39.77 ± 1.59 |
|
2 |
DIAZEPAM |
2 |
13.8 ± 0.34*** |
6.5 ± 0.22*** |
67.98 ± 2.16*** |
|
3 |
HIEE |
100 |
6.5 ± 0.22 |
9 ± 0.36 |
41.94 ± 1.82 |
|
4 |
HIEE |
200 |
8.16 ± 0.30* |
8.33 ± 0.36* |
50.51 ± 2.61* |
|
5 |
HIEE |
400 |
10.83 ± 0.41*** |
7.5 ± 0.22** |
59.09 ± 2.69*** |
Results are shown as MEAN ± SEM (n=6); *P<0.05, **P<0.01, ***P<0.001: when compared to control group by one way ANOVA followed by Dunnett multiple comparison test
Figure 1: Graphical representation for no. of entries in open and closed arms in EPM
Figure: 2 – Graphical representation for percentage open arm entries.
Table 2: Anxiolytic activity profile on total time spent in open and closed arms in sec (Mean ± SEM) of Hemidesmus indicus ethanolic extract in EPM.
|
GROUP NO. |
TREATMENT GROUP |
DOSE (mg/kg) |
Time spent in sec (Mean ± SEM) |
%TSOA (Percentage time spent in open arms) |
|
|
Open arm |
Closed arm |
||||
|
1 |
CONTROL |
saline |
53.33 ± 1.64 |
238.16 ± 2.48 |
18.27 ± 0.59 |
|
2 |
DIAZEPAM |
2 |
161.66 ± 3.37*** |
130 ± 2.12*** |
55.42 ± 1.47*** |
|
3 |
HIEE |
100 |
92.5 ± 1.74* |
194.16 ± 2.08* |
32.28 ± 0.70* |
|
4 |
HIEE |
200 |
136.16 ± 3.87** |
155.33 ± 1.89* |
46.71 ± 1.44** |
|
5 |
HIEE |
400 |
148.67 ± 2.92*** |
146.83 ± 2.65** |
50.31 ± 1.34*** |
Results are shown as MEAN ± SEM (n=6); *P<0.05, **P<0.01, ***P<0.001: when compared to control group by one way ANOVA followed by Dunnett multiple comparison test
Figure 3: Graphical representation for time spent in open and closed arms in EPM
Figure 4: Graphical representation for %TSOA (Percentage time spent in open arms) in EPM
Table 3: Anxiolytic activity profile on light and dark apparatus of Hemidesmus indicus ethanolic extract.
|
GROUP NO. |
TREATMENT GROUP |
DOSE (mg/kg) |
TIME SPENT IN SEC (Mean ± SEM) |
%TSLB (Percentage time spent in light box) (Mean ± SEM) |
|
|
LIGHT |
DARK |
||||
|
1 |
CONTROL |
saline |
44.66 ± 1.83 |
254.66 ± 2.65 |
14.92 ± 3.10 |
|
2 |
DIAZEPAM |
2 |
153.33± 2.73** |
146.16 ± 2.104** |
51.19 ± 1.78*** |
|
3 |
HIEE |
100 |
78 ± 2.54* |
221.33 ± 1.42* |
26.05 ± 3.26** |
|
4 |
HIEE |
200 |
126.83 ± 2.84** |
172.66 ± 2.77** |
42.34 ± 2.24** |
|
5 |
HIEE |
400 |
138.87 ± 2.31*** |
160.16 ± 2.49*** |
46.44 ± 1.66*** |
Results are shown as MEAN ± SEM (n=6); a=P<0.05, b=P<0.01, c=P<0.001: when compared to control group by one way ANOVA followed by Dunnett multiple comparison test
Figure 5: Graphical representation for time spent in light and dark box in LDT
Figure 6: Graphical representation for %TSLB percentage time spent in light and dark box in LDT
Table 4: Anxiolytic activity profile on open field apparatus of Hemidesmus indicus ethanolic extract.
|
GROUP NO. |
TREATMENT GROUP |
DOSE (mg/kg) |
AMBULATION |
NO. OF REARING |
NO. OF ASSISTED REARING |
|
1 |
CONTROL |
saline |
112.5 ± 1.33 |
8.33 ± 0.49 |
18.16 ± 0.47 |
|
2 |
DIAZEPAM |
2 |
192.16 ± 1.57*** |
13.83 ± 0.307*** |
36.33 ± 0.61*** |
|
3 |
HIEE |
100 |
139.66 ± 1.99** |
9.16 ± 0.477 |
22.66 ± 0.91* |
|
4 |
HIEE |
200 |
171 ± 1.36*** |
11.41 ± 0.33** |
32 ± 0.57*** |
|
5 |
HIEE |
400 |
182.21 ± 1.61*** |
11.84 ± 0.47** |
34.5 ± 0.68*** |
Results are shown as MEAN ± SEM (n=6); *P<0.05, **P<0.01, ***P<0.001: when compared to control group by one way ANOVA followed by Dunnett multiple comparison test
Figure 7: Graphical representation for AMBULATION (no. of square crossed) in OFT.
Figure 8: Graphical representation for no. of REARING in OFT.
Figure 9: Graphical representation for no. of assisted rearing in OFT
DISCUSSION
Anxiety disorders are among the most common mental disorders. Anxiety is a typical reaction that includes dread, tension, high blood pressure, perspiration, and trembling. However, when it gets excessive, it has a negative impact on everyday life 17. The plant includes a diverse range of bioactive chemicals, including saponins, tannins, flavonoid ds, steroids, and alkaloids, many of which have pharmacological properties relevant to the central nervous system and may contribute to anxiolytic (anti-anxiety) effects18. The elevated plus maze (EPM) is a popular behavioural assay for measuring anxiety in rodents. In our study, mice administered with the ethanolic extract of Hemidesmus indicus (HIEE) spent more time in the open arms and entered them more frequently than the control group. These behaviours are indicative of decreased anxiety, as rodents naturally avoid open and elevated regions due to their sensitivity to potentially dangerous places. The EPM data imply that HIEE has a relaxing impact on rodents at dose of 200mg/kg and 400mg/kg, lowering their anxiety and increasing their willingness to explore potentially dangerous locations. This experiment gave strong data supporting the anxiolytic effects of HIEE 19,20. In light-dark box test (LDBT) is a popular behavioural assay for detecting anxiety-like behaviours in rodents, taking use of their natural sensitivity to highly lighted environments and preference for dark, confined places21. In our study, mice given the ethanolic extract of Hemidesmus indicus (HEEI) 200mg/kg and 400mg/kg spent much more time in the light compartment than the control, indicating a decrease in anxiety levels. Furthermore, the frequency of transitions between the light and dark compartments was greater in the HIEE- treated group, indicating more exploratory activity and less fearfulness. The results of the LDBT support the anxiolytic effects of HIEE found in other behavioural tests, such as the elevated plus maze (EPM) and the open field test (OFT) 22, 23. The open field test (OFT) results revealed significant evidence for the anxiolytic effects of Hemidesmus indicus' ethanolic extract (HIEE). Treated mice had a much higher number of squares crossed, indicating increased locomotor activity and decreased anxiety. Furthermore, the frequency of rearing, a measure of exploratory behaviour, was significantly higher in the EEHI group than in controls, indicating increased curiosity and decreased fearfulness. The rise in assisted raising, in which rodents explore while leaning against walls, demonstrated a balanced reduction in anxiety while remaining cautious. These behaviours underscore EEHI's anxiolytic effect, complementing the findings of the elevated plus maze (EPM) and light-dark box test (LDBT), and imply that Hemidesmus indicus could be a promising natural anxiety treatment 24. Thus, in this study, both the higher doses of HIEE (200 and 400 mg/kg) and diazepam significantly reduced the anxiety effect in mice and were proven to be effective.
CONCLUSION
The study shows that the ethanolic extract of Hemidesmus indicus (EEHI) has strong anxiolytic activity in mice models and has a good safety profile. These data indicate that EEHI may be a promising natural alternative or complementary therapy for anxiety disorders. However, more study is needed to investigate different extracts, understand mechanisms, optimize dose, and prove efficacy and safety through long-term and clinical investigations. If these procedures are completed successfully, Hemidesmus indicus may be recognized as a viable choice in the pharmaceutical management of anxiety disorders, providing a natural and effective treatment alternative.
REFERENCES
1. Spinella M. Herbal medicines and epilepsy: the potential for benefit and adverse effects. Epilepsy & Behavi. 2001;2(6):524-32. https://doi.org/10.1006/ebeh.2001.0281 PMid:12609386
2. Kamal M, Jawaid T. Herbal drugs in mirror of anxiety disorder-A review. Int J Biomed Res. 2011;2(1):62-72. https://doi.org/10.7439/ijbr.v2i1.81
3. Chatterjee S, Banerjee A, Chandra I. Hemidesmus indicus: A rich source of herbal medicine. Med Aromat Plants 2013;3:e155. https://doi.org/10.4172/2167-0412.1000e155
4. Nair SA, Sabulal B, Radhika J, Arunkumar R, Subramoniam A. Promising anti-diabetes mellitus activity in rats of β-amyrin palmitate isolated from Hemidesmus indicus roots. Eur J Pharmacol. 2014; 734:77-82. https://doi.org/10.1016/j.ejphar.2014.03.050 PMid:24726843
5. Aminuddin GR. Pluralistic folk uses of Hemidesmus indicus (L.) R. Br. from south eastern India. J Econ Taxon Bot. 1991;15:715-8.
6. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13(2):167-70. https://doi.org/10.1016/0091-3057(80)90067-2 PMid:6106204
7. OECD/OCDE. Guidelines for the testing of chemicals, revised draft guidelines 423; acute oral toxicity-acute toxic class method, OECD publishing.2001.
8. Kawlni L, Bora M, Upadhyay SN, Mukherjee K, Hazra J. Pharmacological and therapeutic profile of anantamula (hemidesmus indicus (l.) R. Br.): a comprehensive review. Int J Ayurveda Pharma Res. 2017;5(11):49-57.
9. Kumar D, Kumar S. Evaluation of antianxiety activity of Calotropis gigantea roots. J FundamenT Pharma Res. 2014;2:30-7.
10. Kumar D, Kumar S. Screening of antianxiety activity of Abies pindrow Royle aerial parts. Indian J Pharma Edu Res. 2015;49(1):66-70. https://doi.org/10.5530/ijper.49.1.9
11. Nishino T, Takeuchi T, Takechi K, Kamei C. Evaluation of anxiolytic-like effects of some short-acting benzodiazepine hypnotics in mice. J Pharmacol Sci. 2008;107(3):349-54. https://doi.org/10.1254/jphs.08107FP PMid:18603828
12. Kulkarni SK, Verma A. Protective effect of BR-16A (Mentat), a herbal preparation on alcohol abstinence-induced anxiety and convulsions. Indian J Exp Biol. 1993 31(5):435-9.
13. Rauniar GP, Deo S, Bhattacharya SK. Evaluation of anxiolytic activity of tensarin in mice. Kathmandu University Medical Journal (KUMJ). 2007;5(2):188-94.
14. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L.(mulberry) leaves on anxiety in mice. Indian J Pharmacol. 2008;40(1):32-6. https://doi.org/10.4103/0253-7613.40487 PMid:21264159 PMCid:PMC3023120
15. Nagaraja TS, Mahmood R, Krishna V, Thippeswamy BS, Veerapur VP. Evaluation of anxiolytic effect of Erythrina mysorensis Gamb. in mice. Indian J Pharmacol. 2012;44(4):489-92. https://doi.org/10.4103/0253-7613.99316 PMid:23087511 PMCid:PMC3469953
16. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav. 1989;32(3):777-85. https://doi.org/10.1016/0091-3057(89)90033-6 PMid:2740429
17. Sastri BN. The wealth of India, raw materials. CSIR, New Delhi. 1962; 6:439.
18. Moser DK. "The rust of life": impact of anxiety on cardiac patients. American J Crit Care. 2007;16(4):361-9. https://doi.org/10.4037/ajcc2007.16.4.361
19. Lister RG. Ethologically-based animal models of anxiety disorders. Pharmacol Therap. 1990;46(3):321-40. https://doi.org/10.1016/0163-7258(90)90021-S PMid:2188266
20. File SE. Factors controlling measures of anxiety and responses to novelty in the mouse. Behav Brain Res. 2001;125(1-2):151-7. https://doi.org/10.1016/S0166-4328(01)00292-3 PMid:11682106
21. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980;13(2):167-70. https://doi.org/10.1016/0091-3057(80)90067-2 PMid:6106204
22. Graeff FG, Zangrossi Jr H. Animal models of anxiety disorders. Biol Psychiatry. 2002:877-93. https://doi.org/10.1002/0470854871.chxix1
23. Lepicard EM, Joubert C, Hagneau I, Perez-Diaz F, Chapouthier G. Differences in anxiety-related behavior and response to diazepam in BALB/cByJ and C57BL/6J strains of mice. Pharmacol Biochem Behav. 2000;67(4):739-48. https://doi.org/10.1016/S0091-3057(00)00419-6 PMid:11166064
24. Mechan AO, Moran PM, Elliott MJ, Young AM, Joseph MH, Green RA. A comparison between Dark Agouti and Sprague-Dawley rats in their behaviour on the elevated plus-maze, open-field apparatus and activity meters, and their response to diazepam. Psychopharmacol. 2002; 159:188-95. https://doi.org/10.1007/s002130100902 PMid:11862348